Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with… Feb 17, 2022
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in… Feb 16, 2022
InMed Pharmaceuticals Strengthens Its Commercial Leadership Team With The Appointment Of Vice President Of Sales And… Feb 15, 2022
Awakn Life Sciences’ Professor Celia Morgan Named One Of The Most Influential Women In The Psychedelics Industry Feb 15, 2022
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Feb 14, 2022
HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market Feb 10, 2022
Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of… Feb 9, 2022
Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in Canada Feb 8, 2022
Mindset Pharma Appoints Dr. Fiona Randall as Senior Vice President of External Alliances and Scientific Strategy Feb 8, 2022
